For two decades, Imeik has dedicated itself to R&D in biomedical materials and biopharmaceutical products. We are driven by innovation and committed to delivering safe, effective, high-quality consumer medical products. We leverage our technological leadership, continuously increase R&D investment, and cultivate expert teams. Through collaborations with industry experts, academic laboratories, and specialized institutions, we pioneer cutting-edge biopharmaceutical technologies, relentlessly pursuing the beauty of ‘Research Value’.
Proportion of
R&D Investment
Proportion of
R&D Personnel
Valid Authorized Patents
Invention Patents
Guided by a human-centered medical philosophy and consumer-focused R&D strategy, we expand innovation boundaries and advance our R&D pipeline. We implement incentive-driven innovation systems and foster a talent development mechanism integrating R&D and patent expertise. We unlock growth potential through technological, product, and model innovation, fulfilling our mission to empower lives with confidence and wellness through science.
Our integrated organizational structure spans R&D, production, clinical trials, regulatory affairs, and commercialization. As of December 2024, we hold 11 Class III medical device registrations approved by the NMPA. Simultaneously, we maintain a broad and diversified R&D pipeline, coordinate technology platforms, accelerate product development, and advance global clinical and registration efforts.
In-House R&D
Joint Ventures
Mergers & Acquisitions
Licensing
Global Scaling
